| High-grade glioma treatment response monitoring biomarkers: a position statement on the evidence supporting the use of advanced MRI techniques in the clinic, and the latest … OM Henriksen, M del Mar Álvarez-Torres, P Figueiredo, G Hangel, ... Frontiers in oncology 12, 810263, 2022 | 47 | 2022 |
| MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas E Fuster-Garcia, D Lorente Estellés, MM Álvarez-Torres, ... European Radiology 31, 1738-1747, 2021 | 28 | 2021 |
| Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study M del Mar Álvarez‐Torres, J Juan‐Albarracín, E Fuster‐Garcia, ... Journal of Magnetic Resonance Imaging 51 (5), 1478-1486, 2020 | 27 | 2020 |
| High-grade glioma treatment response monitoring biomarkers: a position statement on the evidence supporting the use of advanced MRI techniques in the clinic, and the latest … TC Booth, EC Wiegers, EAH Warnert, KM Schmainda, F Riemer, ... Frontiers in Oncology 11, 811425, 2022 | 23 | 2022 |
| Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT M Álvarez-Torres, E Fuster-García, C Balaña, J Puig, ... Cancers 13, 2021 | 9 | 2021 |
| Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification MM Álvarez-Torres, E Fuster-García, J Juan-Albarracín, G Reynés, ... BMC cancer 22 (1), 40, 2022 | 8 | 2022 |
| Differential effect of vascularity between long‐and short‐term survivors with IDH1/2 wild‐type glioblastoma MM Álvarez‐Torres, E Fuster‐García, G Reynés, J Juan‐Albarracín, ... NMR in Biomedicine 34 (4), e4462, 2021 | 8 | 2021 |
| ONCOhabitats glioma segmentation model J Juan-Albarracín, E Fuster-Garcia, M del Mar Álvarez-Torres, ... Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries …, 2020 | 7 | 2020 |
| Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype E Chelebian, E Fuster-Garcia, MM Álvarez-Torres, J Juan-Albarracín, ... PloS one 15 (10), e0232500, 2020 | 4 | 2020 |
| Vascular differences between IDH-wildtype glioblastoma and astrocytoma IDH-mutant grade 4 at imaging and transcriptomic levels MM Alvarez-Torres, A López-Cerdán, MI Vaya, E Fuster-Garcia, ... NMR in Biomedicine, https://doi.org/10.1002/nbm.5004, 2023 | 3 | 2023 |
| GET: a foundation model of transcription across human cell types X Fu, S Mo, A Buendia, A Laurent, A Shao, MM Alvarez-Torres, T Yu, ... bioRxiv, 2023.09. 24.559168, 2023 | 1 | 2023 |
| Detection of local microvascular proliferation in IDH wild-type Glioblastoma using relative Cerebral Blood Volume MM Álvarez-Torres, E Fuster-García, J Juan-Albarracín, G Reynés, ... medRxiv, 2021.04. 19.21255589, 2021 | 1 | 2021 |
| Unlocking Bevacizumab’s Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients MM Álvarez-Torres, C Balaña, E Fuster-García, J Puig, JM García-Gómez Cancers 16 (1), 161, 2023 | | 2023 |
| BIOhabitats clinical study (NCT05375318): Histopathological analysis of vascular habitats in glioblastoma defined by perfusion MRI MM Álvarez-Torres, R Burgos-Panadero, JA Martínez, CI Vidal, ... Cancer Research 83 (7_Supplement), 4596-4596, 2023 | | 2023 |
| Characterization of vascular heterogeneity of astrocytomas grade 4 for supporting patient prognosis estimation, and treatment response assessment MM Álvarez Torres Universitat Politècnica de València, 2022 | | 2022 |
| Lack of benefit of temozolomide for MGMT methylated patients with high vascular glioblastoma: a confirmatory study MM Álvarez-Torres, E Fuster-García, C Balaña, J Puig, JM García-Gómez medRxiv, 2021.09. 01.21262673, 2021 | | 2021 |
| Differential effect of MGMT methylation between moderate or high vascular profile in IDH wild-type glioblastoma M del Mar Álvarez-Torres, E Fuster-García, J Juan-Albarracín, J Puig, ... Cancer Research 81 (13_Supplement), 2654-2654, 2021 | | 2021 |
| Preliminarily results of the Oncohabitats Study: A multicentre validation of overall survival (OS) estimation of patients with glioblastoma (GBM) using vascular biomarkers MM Álvarez-Torres, F Bellvís–Bataller, J Juan–Albarracín, ... Cancer Research 79 (13_Supplement), 4258-4258, 2019 | | 2019 |
| Gene Expression Signature in High-Grade Gliomas with MRI-Defined High Vascularity: Prognostic Relevance V Montosa-i-Micó, MM Álvarez-Torres, R Burgos-Panadero, ... Available at SSRN 4620747, 0 | | |
| Relative cerebral blood volume of tumor habitats can differentiate presurgical IDH-wildtype glioblastoma from IDH-mutant astrocytoma grade 4. M del Mar Álvarez-Torres, E Fuster-Garcia, C Balaña, J Puig, G Reynes, ... | | |
